Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier
South San Francisco, Calif. - Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced Read more...
Provision first proton therapy center using new product to benefit prostate cancer patients
KNOXVILLE, Tenn. (WVLT)-- Provision Center for Proton Therapy is helping pioneer a new product that will help further protect prostate cancer patients Read more...
New prostate treatment protects from radiation effects
CHARDON, Ohio -- Two days ago, the FDA approved a new product that protects prostate cancer patients from the side effects of radiation.
It's called Read more...
Immunoassay Confirmation of MRM-MS Data Supports a Role for Acute Phase Proteins in the Prediction of Spontaneous Preterm Birth
Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2015 Annual Meeting. Read more...
First-in human: Tumor suctioned from vein of cancer patient to allow minimally invasive kidney surgery
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing Read more...
Discovery Assay Development of Biomarkers Predictive of Preterm Birth
Sera Prognostics, Inc. presented the development and analytical performance of a highly multiplexed and targeted mass spectrometry-based assay for biomarker Read more...
